microdosing glp-1 agonists Can GLP 1 Enhance Fat Loss During the Fitness Definition Phase? Why GLP-1 Microdosing? A Closer

Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide

As we await prospective data, clinical practice should consider the difference between abrupt stop vs gradual taper when counseling patients about expectations after therapy

Meanwhile, orforglipron demonstrated significant weight loss efficacy [8] consistent with injectable GLP-1 medicines

Intention-to-treat analyses resulted in an HR of 1.36 (95% CI 0.51, 3.61)

Is berberine a GLP-1 agonist

Novo Nordisk is putting down up to US$362m to tap into Ascendis TransCon technology for treatments in metabolic and cardiovascular diseases